A 28-Year Study of the Course of Hepatitis Δ Infection: A Risk Factor for Cirrhosis and Hepatocellular Carcinoma
To access this article, please choose from the options below
Conflicts of interest The authors disclose the following: M. Colombo is advisor and served as a speaker bureau for Roche, Schering Plough, Glaxo Smith Kline, and Gilead. The remaining authors disclose no conflicts.
Funding Supported by a grant from University of Milan (“First Project”) and a grant from Fondazione IRCCS Maggiore Hospital Mangiagalli and Regina Elena (“Ricerca Corrente 2008”).
PII: S0016-5085(09)00154-1
doi:10.1053/j.gastro.2009.01.052
© 2009 AGA Institute. Published by Elsevier Inc. All rights reserved.

